SK117298A3 - Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives - Google Patents
Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives Download PDFInfo
- Publication number
- SK117298A3 SK117298A3 SK1172-98A SK117298A SK117298A3 SK 117298 A3 SK117298 A3 SK 117298A3 SK 117298 A SK117298 A SK 117298A SK 117298 A3 SK117298 A3 SK 117298A3
- Authority
- SK
- Slovakia
- Prior art keywords
- derivative
- benzylaziridine
- derivatives
- substituted
- sulfuric acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Oblasť technikyTechnical field
Vynález sa týka spôsobu prípravy 1,4,7,10-tetraazacyklododekánu (cyklén) a jeho derivátov.The present invention relates to a process for the preparation of 1,4,7,10-tetraazacyclododecane (cyclene) and derivatives thereof.
Doterajší stav technikyBACKGROUND OF THE INVENTION
1,4,7,10-tetraazacyklododekán (cyklén) má široké využitie nielen ako makrocyklický ligand, ale tiež ako edukt pri príprave rôznych, kov obsahujúcich, farmaceutický používaných komplexov, ako napríklad gadobutrol (INN), gadobenat (INN) alebo gadoteridol (INN).1,4,7,10-tetraazacyclododecane (cyclene) is widely used not only as a macrocyclic ligand, but also as a starting material in the preparation of various metal-containing, pharmaceutically used complexes such as gadobutrol (INN), gadobenate (INN) or gadoteridol (INN) ).
1,4,7,10-tetraazacyklododekán je spravidla pripravovaný niekoľkostupňovou syntézou cyklickou kondenzáciou dvoch lineárnych východiskových produktov (J. Chem. Rev. 1989, 929, The Chemistry of Macrocyclic Ligand Complexes, Cambridge University Press, Cambridge, U.K. 1989).1,4,7,10-tetraazacyclododecane is generally prepared by a multi-step synthesis by cyclic condensation of two linear starting products (J. Chem. Rev. 1989, 929, The Chemistry of Macrocyclic Ligand Complexes, Cambridge University Press, Cambridge, U.K. 1989).
Nevýhodou tejto metódy je vysoký počet stupňov syntézy, nízky celkový výťažok, ako i vysoké množstvo z toho vzniknutých anorganických solí, ktoré vzniknú počas syntézy.The disadvantage of this method is the high number of synthesis steps, the low overall yield, and the high amount of the inorganic salts formed therefrom, which are formed during the synthesis.
Podstatne jednoduchší spôsob prípravy 1,4,7,10-tetraazacyklo-dodekánu predstavuje cyklotetramerizácia N-substituovaných aziridínov. V odbornej literatúre sú popísané rôzne varianty tejto reakcie. Pritom je najprv z benzyletanolamínu pripravený zodpovedajúci N-substituovaný aziridín a potom izolovaný. Aziridín je potom v prítomnosti Brónstedových kyselín ako napríklad p-TsOH (J. Heterocyclic Chem. 1968, 305) alebo Lewisových kyselín ako napríklad trialkylhliník (US patent 3,828,023) alebo BF3-eterát (Tetrahedron Letters, 1970, 1367), v malom výťažku cyklotetramerizovaný. Hoci je tento spôsob vykonateľný iba na prípravu malých množstiev (menšie ako 5 g), tvorí, ešte 16 rokov po prvej publikácii, stav techniky (WO 95/31444).The cyclotetramerization of N-substituted aziridines is a substantially simpler method of preparing 1,4,7,10-tetraazacyclododecane. Various variants of this reaction are described in the literature. The corresponding N-substituted aziridine is first prepared from benzylethanolamine and then isolated. Aziridine is then in low yield in the presence of Bronsted acids such as p-TsOH (J. Heterocyclic Chem. 1968, 305) or Lewis acids such as trialkyl aluminum (US patent 3,828,023) or BF 3 -etherate (Tetrahedron Letters, 1970, 1367). cyklotetramerizovaný. Although this method is feasible only for the preparation of small quantities (less than 5 g), it still constitutes, prior to 16 years after the first publication, a prior art (WO 95/31444).
31047/H31047 / H
Všetky doteraz popísané cyklotetramerizačné reakcie vyžadujú použitie čistých aziridínov, ktoré, ako je známe, vykazujú silné mutagénne a rakovinotvorné účinky (Roth, Giftliste, VCH Weinheim). Z tohto dôvodu je cyklomerizácia aziridínov, ktorá sa zdá ako najľahší spôsob prípravy 1,4,7,10-tetraazacyklododekánu, bez praktického využitia v technickom meradle. Z toho vyplýva veľký záujem o technicky uskutočniteľný, životné prostredie málo znečisťujúci a podstatne bezpečnejší spôsob prípravy 1,4,7,10-tetraazacyklododekánu.All of the hitherto described cyclotetramerization reactions require the use of pure aziridines which, as is known, have potent mutagenic and carcinogenic effects (Roth, Giftliste, VCH Weinheim). For this reason, the cyclomerization of aziridines, which seems to be the easiest way to prepare 1,4,7,10-tetraazacyclododecane, is practically non-commercial. This implies great interest in a technically feasible, environmentally less polluting and substantially safer process for preparing 1,4,7,10-tetraazacyclododecane.
Podstata vynálezuSUMMARY OF THE INVENTION
Úlohou predloženého vynálezu teda je vypracovať praktikovateľný spôsob prípravy 1,4,7,10-tetraazacyklododekánu v technickom meradle, ktorý prekoná vyššie uvedené nevýhody a hlavne sa vyhne ľudskému ohrozeniu mutagénnymi a rakovinotvornými aziridínovými medzistupňami.It is therefore an object of the present invention to provide a practicable process for the preparation of 1,4,7,10-tetraazacyclododecane on an industrial scale that overcomes the above-mentioned disadvantages and, in particular, avoids the human threat to mutagenic and cancer-causing aziridine intermediate steps.
Táto úloha je vyriešená spôsobom podľa vynálezu. Jedná sa pritom o spôsob prípravy derivátov cyklénu cyklotetramerizáciou derivátov benzylaziridínu, ktorého podstata spočíva v tom, že sa derivát benzylaziridínu pripraví in situ a bez izolácie sa tetramerizuje pridaním silnej kyseliny k derivátu tetrabenzylcyklénu a nakoniec sa benzylové skupiny oddelia hydrogenáciou.This object is achieved by the method according to the invention. It is a process for the preparation of cyclic derivatives by cyclotetramerization of benzylaziridine derivatives, which is characterized in that the benzylaziridine derivative is prepared in situ and, without isolation, is tetramerized by adding a strong acid to the tetrabenzylcyclene derivative and finally the benzyl groups are separated by hydrogenation.
V rámci predloženého vynálezu výraz derivát cyklénu zahrňuje nielenIn the present invention, the term cyclene derivative includes not only
1,4,7,10-tetraazacyklododekán, ale tiež také deriváty, u ktorých etylénové mostíky majú alkylové substituenty. Takto zahrňuje pojem derivát cyklénu napríklad zlúčeniny [2S-(2a,5α,8a, 11a)]-2,5,8,11-tetrametyl-1,4,7,10-tetraazacyklodo-dekán a [2S(2α, 5α,8a, 11 a)]-2,5,8,11 -tetraetyl-1,4,7,10-tetraazacyklodo-dekán.1,4,7,10-tetraazacyclododecane, but also those derivatives in which the ethylene bridges have alkyl substituents. Thus, the term cyclene derivative includes, for example, [2S- (2a, 5α, 8a, 11a)] - 2,5,8,11-tetramethyl-1,4,7,10-tetraazacyclododecane and [2S (2α, 5α, 8a, 11a)] - 2,5,8,11-Tetraethyl-1,4,7,10-tetraazacyclododecane.
Analogickým spôsobom výraz derivát tetrabenzylcyklénu v rámci predloženého vynálezu zahrňuje ako 1,4,7,10-tetrabenzyl-1,4,7,10tetraazacyklododekán, tak tiež deriváty, u ktorých etylénové mostíky majú alkylových substituentov. Výraz derivát benzylaziridínu v rámci predloženého vynálezu zahrňuje benzylaziridín, ako i také deriváty, u ktorých aziridínový kruh má alkylových substituentov. Takto zahrňuje pojem derivát benzylaziridínu napríklad tiež zlúčeninu (S)-1-benzyl-2-metyl-aziridín a (S)-1-benzyl-2-etyl-aziridín.By analogy, the term tetrabenzylcyclene derivative within the scope of the present invention includes both 1,4,7,10-tetrabenzyl-1,4,7,10tetraazacyclododecane and derivatives wherein ethylene bridges have alkyl substituents. The term benzylaziridine derivative within the scope of the present invention includes benzylaziridine as well as those derivatives in which the aziridine ring has alkyl substituents. Thus, the term benzylaziridine derivative includes, for example, the compound (S) -1-benzyl-2-methyl-aziridine and (S) -1-benzyl-2-ethyl-aziridine.
31047/H31047 / H
Vynález teda zahrňuje spôsob prípravy prípadne substituovaných derivátovThus, the invention includes a process for preparing optionally substituted derivatives
1,4,7,10-tetraazacyklododekánu tetramerizáciou zodpovedajúcich eduktov. Výhodne zahrňuje vynález prípravu 1,4,7,10-tetraazacyklododekánu.1,4,7,10-tetraazacyclododecane by tetramerization of the corresponding starting materials. Preferably, the invention includes the preparation of 1,4,7,10-tetraazacyclododecane.
Výhodná forma vyhotovenia vychádza z ľahko dostupného benzyletanolamínu, ktorý sa zahrievaním (80 - 150 °C, výhodne 90 - 110 °C) s 1 až 1,4 ekvivalentmi koncentrovanej kyseliny sírovej v organickom rozpúšťadle (napríklad toluén, cyklohexán, heptán, atď., koncentrácie: 10-20 %) a azeotropnou destiláciou pritom vzniknutej vody premení na zodpovedajúci ester kyseliny sírovej. Reakcia pritom trvá 2 až 10 hodín. Ester sa potom zahrieva s 2 až 5 ekvivalentmi vodných lúhov (napríklad NaOH, KOH) a pritom vzniknutý benzylaziridín sa v druhej reakčnej nádobe, ktorý s prvou tvorí uzatvorený systém, neustále azeotropne oddestilováva s vodou. Tým vzniknutá vodná benzylaziridínová emulzia sa môže, po zriedení organickým rozpúšťadlom (napríklad etanolom, metanolom, THF), neustálym pridávaním aspoň 0,25 až 0,4 mól (výhodne 0,25 až 0,35 mól) silnej kyseliny na mól benzylaziridínu (to znamená ekvivalentné množstvo kyseliny vzhľadom k produktu) prekvapujúco úplne premeniť na tetrabenzylcyklén.A preferred embodiment starts from readily available benzylethanolamine, which is heated (80-150 ° C, preferably 90-110 ° C) with 1 to 1.4 equivalents of concentrated sulfuric acid in an organic solvent (e.g. toluene, cyclohexane, heptane, etc., concentration: 10-20%) and converted into the corresponding sulfuric acid ester by azeotropic distillation. The reaction takes 2 to 10 hours. The ester is then heated with 2 to 5 equivalents of aqueous lyes (e.g. NaOH, KOH) and the benzylaziridine formed therefrom is continuously azeotroped with water in a second reaction vessel, which first forms a closed system. The resulting aqueous benzylaziridine emulsion can, after dilution with an organic solvent (e.g., ethanol, methanol, THF), by continuously adding at least 0.25 to 0.4 mol (preferably 0.25 to 0.35 mol) of strong acid per mole of benzylaziridine (i.e. surprisingly, the equivalent amount of acid relative to the product) is completely converted to tetrabenzylcyclene.
Ako organické rozpúšťadlo možno použiť napríklad etanol, metanol alebo tetrahydrofurán (THF). Ako silná kyselina môže byť použitá para-toluénsulfónová kyselina (p-TsOH), metánsulfónová kyselina (MsOH), kyselina sírová alebo BF3eterát.As the organic solvent, for example, ethanol, methanol or tetrahydrofuran (THF) can be used. As a strong acid, para-toluenesulfonic acid (p-TsOH), methanesulfonic acid (MsOH), sulfuric acid or BF 3 etherate can be used.
Produkt sa získa po alkalizácii (0,2 až 0,5 ekvivalentov bázy, napríklad NaOH, KOH) reakčnej zmesi kryštalizáciou v polárnych rozpúšťadlách (napríklad THF, etanol, acetón, izopropanol, dietyléter, etylacetát, furán, dioxan, voda alebo ich zmesí) a hneď potom sa hydrogenuje s pomocou katalyzátora (Pd/C, množstvo 5 až 20 % vzťahujúc na derivát tetrabenzylcyklénu, tlak 0,1 až 2,0 MPa). Po filtrácii katalyzátora a oddestilovaní rozpúšťadla sa získa 1,4,7,10-tetraazacyklododekán s výťažkom 45 až 60 % celkového teoretického výťažku.The product is obtained after alkalization (0.2 to 0.5 equivalents of base, e.g. NaOH, KOH) of the reaction mixture by crystallization in polar solvents (e.g. THF, ethanol, acetone, isopropanol, diethyl ether, ethyl acetate, furan, dioxane, water or mixtures thereof) and then hydrogenated with the aid of a catalyst (Pd / C, 5 to 20% based on the tetrabenzylcyclene derivative, at a pressure of 0.1 to 2.0 MPa). After filtering the catalyst and distilling off the solvent, 1,4,7,10-tetraazacyclododecane is obtained in a yield of 45 to 60% of the total theoretical yield.
Analogicky k tejto syntéze sa môže tiež použiť alkylom substituovaný benzyletanolamín, napríklad L-2-benzylaminopropanol alebo L-2-benzylaminobutanol, na získanie derivátov cyklénu, vykazujúcich rozvetvenie na etylénových mostíkoch. Vo výhodnom spôsobe vykonania tejto syntézy sa analogicky k vyššie popísanému procesu získa (S)-1-benzyl-2-metyl-aziridín z L-2-benzylaminopropcinoluBy analogy to this synthesis, an alkyl-substituted benzylethanolamine, for example L-2-benzylaminopropanol or L-2-benzylaminobutanol, can also be used to obtain cyclene derivatives having branching on ethylene bridges. In a preferred embodiment of this synthesis, (S) -1-benzyl-2-methyl-aziridine from L-2-benzylaminopropcinol is obtained analogously to the process described above.
3l047/H a bez izolácie sa tetramerizáciou premení na [2S-(2a,5a,8a,11a)]-2,5,8,11tetrametyl-1,4,7,10-tetraaza(benzyl)-1,4,7,10-tetraazacyklododekán, z ktorého sa hydrogenáciou získa [2S-(2a,5a,8a, 11 a)]-2,5,8,11 -tetrametyl-1,4,7,10-tetraazacyklododekán.3.1047 / H and without isolation, transforms to [2S- (2a, 5a, 8a, 11a)] - 2,5,8,11-tetramethyl-1,4,7,10-tetraaza (benzyl) -1,4,7 by tetramerization 10-tetraazacyclododecane, from which [2S- (2a, 5a, 8a, 11a)] - 2,5,8,11-tetramethyl-1,4,7,10-tetraazacyclododecane is obtained by hydrogenation.
Spôsob cyklotetramerizácie derivátov benzylaziridínu podľa vynálezu sa od spôsobov podľa známeho stavu techniky odlišuje tým, že nie je nutná žiadna izolácia aziridínu v čistej forme. Popísaný spôsob umožňuje takto vykonanie postupu v uzatvorenom systéme, a tým i vylúčenie ohrozenia človeka a životného prostredia rakovinotvorným aziridínmi.The cyclotetramerization of the benzylaziridine derivatives of the invention differs from the prior art methods in that no isolation of the aziridine in pure form is necessary. The method thus described allows the process to be carried out in a closed system and thus avoids the risk to humans and the environment from cancer-causing aziridines.
Na rozdiel od známeho spôsobu cyklotetramerizácie benzylaziridínov podľa známeho stavu techniky, sa namiesto katalytického množstva kyseliny (p-TsOH, MsOH, kyselina sírová, BF3-eterát alebo trialkylhliník) používa stechiometrické množstvo (0,25 až 0,35 mól, vzťahujúc na jeden mól benzylaziridínu).In contrast to the known prior art cyclotetramerization of benzylaziridines, a stoichiometric amount (0.25 to 0.35 mol, relative to one acid) is used instead of a catalytic amount of acid (p-TsOH, MsOH, sulfuric acid, BF 3 -etherate or trialkyl aluminum). mole of benzylaziridine).
Pri pokusoch vykonať známy spôsob vo zväčšenom meradle a získať tak touto cestou väčšie množstvo 1,4,7,10-tetraazacyklododekánu, bolo použitím katalytických množstiev p-TsOH pri premene in situ vzniknutej benzylaziridínovej emulzie dosiahnutých iba 12 až 25 % teoretického výťažku. V súčasnosti sa prekvapujúco zistilo, že stálym pridávaním od 0,25 do 0,35 ekvivalentov p-TsOH (vzťahujúc na benzylaziridín) pri teplote 60 až 78 °C počas 6 až 9 hodín kazeotropne oddestilovanej benzylaziridínovej emulzii, bol výťažok 1,4,7,10tetrabenzyl-1,4,7,10-tetraazacyklododekánu zlepšený na 60 až 65 % teoretického výťažku.When attempting to carry out the known process on a larger scale and thereby obtaining a larger amount of 1,4,7,10-tetraazacyclododecane, using only catalytic amounts of p-TsOH in converting the in situ benzylaziridine emulsion produced, only 12-25% of the theoretical yield was achieved. It has now surprisingly been found that by continuously adding from 0.25 to 0.35 equivalents of p-TsOH (relative to benzylaziridine) at 60-78 ° C for 6 to 9 hours of caseotropically distilled benzylaziridine emulsion, the yield was 1,4,7,7 10-tetrabenzyl-1,4,7,10-tetraazacyclododecane improved to 60-65% of the theoretical yield.
Ďalšie výhody tohto spôsobu sú vo vysokom celkovom výťažku a v malých množstvách odpadu (síran sodný pri príprave aziridínu a toluén pri hydrogenácii) v porovnaní so známymi spôsobmi.Further advantages of this process are in high overall yield and in small amounts of waste (sodium sulfate in the preparation of aziridine and toluene in hydrogenation) as compared to the known methods.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Nasledujúce príklady majú za úlohu objasniť predmet vynálezu bez toho, aby ho týmto spôsobom obmedzovali.The following examples are intended to illustrate the invention without limiting it.
Príklad 1Example 1
K roztoku s 95 ml benzyletanolamínu v 690 ml toluénu sa pridá 53 ml koncentrovanej kyseliny sírovej. Vzniknutá suspenzia sa zahrieva dve hodiny k varu. Voda (14 ml),To a solution of 95 ml of benzylethanolamine in 690 ml of toluene is added 53 ml of concentrated sulfuric acid. The resulting suspension was heated to boiling for two hours. Water (14 ml),
J47/H ktorá pri tom vznikne, sa oddelí pomocou odlučovača vody. Po ochladení na 20 °C sa reakčná zmes zmieša s 1 300 ml vody, 10 minút sa mieša a organická fáza sa oddelí. Hneď potom sa vodná fáza plynulo pridá k roztoku 92,2 g NaOH v 95 ml vody pripraveného v druhej reakčnej nádobe. Reakčná zmes sa privedie zahrievaním do varu. Destilačným mostíkom sa 880 g vodnej N-benzylaziridínovej emulzie oddestiluje do tretej reakčnej nádoby. Emulzia sa zmieša s 880 ml etanolu a zahrieva sa na 60 °C. K nej sa pridáva dávkovacím čerpadlom v priebehu 8 hodín roztok 38,0 g p-TsOH v 19 ml vody. Po skončenom pridávaní sa zmes dve hodiny zahrieva na teplotu spätného toku. Hneď potom sa reakčná zmes zmieša s roztokom 12,0 g NaOH v 20 ml vody. Takto vzniknutý produkt sa filtruje a rekryštalizuje sa zo 600 ml zmesi 2 : 1 etanol - THF. Takto získaný tetrabenzylcyklén (53 g) sa rozpustí v 500 ml izopropanolu a hydrogenuje sa s 10 g Pd/C (10 %) pri 80 °C a tlaku H2 2,0 MPa. Po odfiltrovaní katalyzátora sa reakčný roztok zahustí a produkt sa rekryštalizuje z toluénu. Takto sa získa 15,9 g (výťažok 55 %) cyklénu, vo forme bezfarebných kryštálov. Teplota topenia 110 až 112 °C.The J47 / H formed is separated by means of a water separator. After cooling to 20 ° C, the reaction mixture is treated with 1300 ml of water, stirred for 10 minutes and the organic phase is separated. Immediately thereafter, the aqueous phase is added continuously to a solution of 92.2 g of NaOH in 95 ml of water prepared in the second reaction vessel. The reaction mixture is brought to reflux by heating. By distillation, 880 g of an aqueous N-benzylaziridine emulsion was distilled off into a third reaction vessel. The emulsion is mixed with 880 ml of ethanol and heated to 60 ° C. A solution of 38.0 g of p-TsOH in 19 ml of water was added via metering pump over 8 hours. After the addition was complete, the mixture was heated to reflux for two hours. Immediately thereafter, the reaction mixture was treated with a solution of 12.0 g of NaOH in 20 ml of water. The product thus formed is filtered and recrystallized from 600 ml of a 2: 1 mixture of ethanol - THF. The tetrabenzylcyclene (53 g) thus obtained was dissolved in 500 ml of isopropanol and hydrogenated with 10 g of Pd / C (10%) at 80 ° C and a H 2 pressure of 20 bar. After filtering off the catalyst, the reaction solution is concentrated and the product is recrystallized from toluene. 15.9 g (yield 55%) of cyclene are thus obtained in the form of colorless crystals. Mp 110-112 ° C.
Príklad 2 ml benzyletanolamínu sa pripraví tak, ako je popísané v príklade 1 pomocou kyseliny sírovej a potom s NaOH. Vzniknutá vodná emulzia N-benzylaziridínu sa zmieša s 2,6 I etanolu a zahrieva na 50 °C. K tomu sa pridá dávkovacím čerpadlom v priebehu 8 hodín roztok 29,3 g p-TsOH v 15 ml vody. Po skončení pridávania sa zmes dve hodiny zahrieva pri teplote spätného toku. Hneď potom sa reakčná zmes zmieša s roztokom 9,5 g NaOH v 20 ml vody. Takto vzniknutý produkt sa filtruje a rekryštalizuje zo 600 ml 2 : 1 zmesi etanol - THF. Takto získaný tetrabenzylcyklén (55,7 g) sa rozpustí v 500 ml izopropanolu a hydrogenuje s 10 g Pd/C (10 %) pri 80 °C a tlaku H2 2,0 MPa. Po odfiltrovaní katalyzátora sa reakčná zmes zahustí a produkt sa rekryštalizuje z toluénu. Takto sa získa 15,9 g (výťažok 58 %) cyklénu vo forme bezfarebných kryštálov. Teplota topenia 111 až 113 °C.Example 2 ml of benzylethanolamine was prepared as described in Example 1 with sulfuric acid and then with NaOH. The resulting aqueous N-benzylaziridine emulsion was mixed with 2.6 L of ethanol and heated to 50 ° C. To this was added a solution of 29.3 g of p-TsOH in 15 ml of water over 8 hours via a metering pump. After the addition was complete, the mixture was heated at reflux for two hours. Immediately thereafter, the reaction mixture was mixed with a solution of 9.5 g NaOH in 20 ml water. The product thus formed is filtered and recrystallized from 600 ml of a 2: 1 mixture of ethanol-THF. The tetrabenzylcyclene (55.7 g) thus obtained was dissolved in 500 ml of isopropanol and hydrogenated with 10 g of Pd / C (10%) at 80 ° C and a H 2 pressure of 20 bar. After filtering off the catalyst, the reaction mixture is concentrated and the product is recrystallized from toluene. 15.9 g (58% yield) of cyclene are thus obtained as colorless crystals. Mp 111-113 ° C.
Príklad 3Example 3
Ako v príklade 1, len tetramerizácia sa vykonáva s 0,33 ekvivalentmi kyseliny metánsulfónovej. Výťažok 52 % cyklénu. Teplota topenia 110 až 112 °C.As in Example 1, only tetramerization was performed with 0.33 equivalents of methanesulfonic acid. Yield 52% cyclene. Mp 110-112 ° C.
Tabuľka 1 Porovnávací prehľad reakčných podmienok a výťažkov syntézyTable 1 Comparative overview of reaction conditions and synthesis yields
31047/H cyklónu cyklotetramerizáciou benzylaziridínu31047 / H cyclone by cyclotetramerization of benzylaziridine
* Lit. 1: J. Heterocyclic Chem. 1968, 305* Lit. 1: J. Heterocyclic Chem. 1968, 305
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19608307A DE19608307C1 (en) | 1996-02-26 | 1996-02-26 | Process for the preparation of 1,4,7,10-tetraazacyclododecane and its derivatives |
PCT/EP1997/000927 WO1997031905A1 (en) | 1996-02-26 | 1997-02-26 | Process for preparing 1,4,7,10-tetraazacyclododecane and its derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
SK117298A3 true SK117298A3 (en) | 1999-01-11 |
SK281972B6 SK281972B6 (en) | 2001-09-11 |
Family
ID=7787168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1172-98A SK281972B6 (en) | 1996-02-26 | 1997-02-26 | Process for preparing alkylsubstituted cyclene derivatives |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0883610B1 (en) |
JP (2) | JP4745469B2 (en) |
KR (1) | KR100453668B1 (en) |
CN (1) | CN1081186C (en) |
AT (1) | ATE194602T1 (en) |
AU (1) | AU717720B2 (en) |
CA (1) | CA2247265C (en) |
CZ (1) | CZ290128B6 (en) |
DE (2) | DE19608307C1 (en) |
DK (1) | DK0883610T3 (en) |
ES (1) | ES2148837T3 (en) |
GR (1) | GR3034468T3 (en) |
HK (1) | HK1018618A1 (en) |
IL (1) | IL125419A (en) |
NO (1) | NO310870B1 (en) |
NZ (1) | NZ331520A (en) |
PL (1) | PL185927B1 (en) |
PT (1) | PT883610E (en) |
SK (1) | SK281972B6 (en) |
WO (1) | WO1997031905A1 (en) |
ZA (1) | ZA971672B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19608307C1 (en) * | 1996-02-26 | 1997-08-28 | Schering Ag | Process for the preparation of 1,4,7,10-tetraazacyclododecane and its derivatives |
CZ2005653A3 (en) * | 2005-10-17 | 2007-01-10 | Azacycles S. R. O. | Process for preparing 1,4,7,10-tetraazacyclododecane and N-acyl derivatives thereof |
DE102009057274B4 (en) | 2009-12-02 | 2011-09-01 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol preparation using trioxobicyclo-octane |
DE102010013833A1 (en) | 2010-03-29 | 2011-09-29 | Bayer Schering Pharma Aktiengesellschaft | Producing gadolinium complex of N-(hydroxymethyl-dihydroxypropyl)-triscarboxymethyl-tetraazacyclododecane useful as magnetic resonance imaging contrast agent, comprises e.g. reacting cyclic compound with dimethylformamide dimethylacetal |
CN101845112B (en) * | 2010-06-02 | 2011-09-14 | 华东理工大学 | Preparation method of high-flexibility nuclear magnetic resonance imaging contrast agents based on high molecular nanometer particles |
DE102010023105A1 (en) | 2010-06-04 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrol preparation in a one-pot process using DMF-acetal and N-methylimidazole |
RS60001B1 (en) | 2011-04-21 | 2020-04-30 | Bayer Ip Gmbh | Preparation of high-purity gadobutrol |
KR102067551B1 (en) * | 2018-04-12 | 2020-01-17 | (주) 에프엔지리서치 | Compounds for remediating the contaminated soil or water |
CN108794417A (en) * | 2018-08-04 | 2018-11-13 | 许昌恒生制药有限公司 | A kind of preparation method of medical diagnosis contrast agent intermediate |
EP4335461A1 (en) | 2022-09-09 | 2024-03-13 | Bayer AG | Combinations of contrast agents |
EP4335840A1 (en) | 2022-09-09 | 2024-03-13 | Bayer Aktiengesellschaft | New contrast agents for use in diagnostic imaging |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3828023A (en) * | 1971-09-13 | 1974-08-06 | Dow Chemical Co | Process for preparing cyclic oligomers of n-substituted aziridines |
US6693190B1 (en) * | 1994-05-11 | 2004-02-17 | Bracco International B.V. | Enhanced relaxivity monomeric and multimeric compounds |
CN1181751A (en) * | 1995-03-10 | 1998-05-13 | 耐克麦德瑟鲁塔公司 | Prepn. of N-arylmethyl axiridine derivatives, 1, 4, 7, 10 -Tetraazacyclododecane derivatives obtained therefrom and N -arylmethyl -ethanol -amine sulphonate esters as intermediates |
DE19608307C1 (en) * | 1996-02-26 | 1997-08-28 | Schering Ag | Process for the preparation of 1,4,7,10-tetraazacyclododecane and its derivatives |
-
1996
- 1996-02-26 DE DE19608307A patent/DE19608307C1/en not_active Expired - Fee Related
-
1997
- 1997-02-26 CN CN97192459A patent/CN1081186C/en not_active Expired - Lifetime
- 1997-02-26 PL PL97328468A patent/PL185927B1/en unknown
- 1997-02-26 WO PCT/EP1997/000927 patent/WO1997031905A1/en active IP Right Grant
- 1997-02-26 SK SK1172-98A patent/SK281972B6/en not_active IP Right Cessation
- 1997-02-26 AT AT96946361T patent/ATE194602T1/en active
- 1997-02-26 JP JP53059297A patent/JP4745469B2/en not_active Expired - Lifetime
- 1997-02-26 DE DE59702009T patent/DE59702009D1/en not_active Expired - Lifetime
- 1997-02-26 IL IL12541997A patent/IL125419A/en not_active IP Right Cessation
- 1997-02-26 EP EP96946361A patent/EP0883610B1/en not_active Expired - Lifetime
- 1997-02-26 CZ CZ19982721A patent/CZ290128B6/en not_active IP Right Cessation
- 1997-02-26 NZ NZ331520A patent/NZ331520A/en not_active IP Right Cessation
- 1997-02-26 DK DK96946361T patent/DK0883610T3/en active
- 1997-02-26 ZA ZA9701672A patent/ZA971672B/en unknown
- 1997-02-26 AU AU18772/97A patent/AU717720B2/en not_active Expired
- 1997-02-26 ES ES96946361T patent/ES2148837T3/en not_active Expired - Lifetime
- 1997-02-26 CA CA002247265A patent/CA2247265C/en not_active Expired - Lifetime
- 1997-02-26 KR KR10-1998-0706649A patent/KR100453668B1/en not_active IP Right Cessation
- 1997-02-26 PT PT96946361T patent/PT883610E/en unknown
-
1998
- 1998-08-25 NO NO19983901A patent/NO310870B1/en not_active IP Right Cessation
-
1999
- 1999-08-27 HK HK99103678A patent/HK1018618A1/en not_active IP Right Cessation
-
2000
- 2000-09-21 GR GR20000402157T patent/GR3034468T3/en unknown
-
2009
- 2009-05-27 JP JP2009127490A patent/JP2009185077A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2247265A1 (en) | 1997-09-04 |
EP0883610A1 (en) | 1998-12-16 |
NO310870B1 (en) | 2001-09-10 |
NZ331520A (en) | 2000-01-28 |
HK1018618A1 (en) | 1999-12-30 |
GR3034468T3 (en) | 2000-12-29 |
IL125419A0 (en) | 1999-03-12 |
WO1997031905A1 (en) | 1997-09-04 |
NO983901D0 (en) | 1998-08-25 |
CZ272198A3 (en) | 2000-02-16 |
AU717720B2 (en) | 2000-03-30 |
KR100453668B1 (en) | 2004-12-16 |
CN1211975A (en) | 1999-03-24 |
ATE194602T1 (en) | 2000-07-15 |
EP0883610B1 (en) | 2000-07-12 |
IL125419A (en) | 2001-01-11 |
CZ290128B6 (en) | 2002-06-12 |
PL185927B1 (en) | 2003-09-30 |
CA2247265C (en) | 2005-06-21 |
DK0883610T3 (en) | 2000-09-25 |
JP4745469B2 (en) | 2011-08-10 |
PL328468A1 (en) | 1999-02-01 |
PT883610E (en) | 2000-10-31 |
ES2148837T3 (en) | 2000-10-16 |
SK281972B6 (en) | 2001-09-11 |
DE19608307C1 (en) | 1997-08-28 |
DE59702009D1 (en) | 2000-08-17 |
CN1081186C (en) | 2002-03-20 |
JP2009185077A (en) | 2009-08-20 |
KR19990087248A (en) | 1999-12-15 |
AU1877297A (en) | 1997-09-16 |
NO983901L (en) | 1998-08-25 |
JP2000505467A (en) | 2000-05-09 |
ZA971672B (en) | 1997-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009185077A (en) | Method for producing 1,4,7,10-tetraazacyclododecane | |
IE842652L (en) | 2-mercapto-imidazoles | |
NO128569B (en) | ||
SU1021342A3 (en) | Process for preparing derivatives of piperidine propyl or their pharmacologically acceptable salts | |
Simay et al. | Oxidation of aryloxyaminoalcohols with activated dimethylsulfoxide; a novel CN oxidation facilitated by neighboring group effect | |
EP0252353B1 (en) | 4-benzyloxy-3-pyrrolin-2-one-1-yl-acetamide, preparation and use | |
US5744616A (en) | Process for the production of 1,4,7,10-tetraazacyclododecane and its derivatives | |
US3201406A (en) | Pyridylcoumarins | |
FI61880B (en) | EXAMINATION OF N-ARYL SULPHONYL-N '- (3-AZABICYCLOALKYL) -URINAEMNEN | |
AU2018374838B2 (en) | Process for preparing acylated amphetamine derivatives | |
BG63917B1 (en) | 1-ar(alk)yl-imidazolin-2-ones with disubstituted amine residue in the 4th place, with anti-convulsive effect and method for their preparation | |
Kruse et al. | Single‐step conversion of aliphatic, aromatic and heteroaromatic primary amines into piperazine‐2, 6‐diones | |
EP0293814A1 (en) | Mono- and polyhydroxyacyl derivatives of polyoxygenated labdanes, a process for their production and their use as drugs | |
US4010160A (en) | Process for the manufacture of 1,3-bis-(β-ethylhexyl)-5-amino-5-methyl-hexahydropyrimidine | |
DE3403778A1 (en) | CYANOMETHYL- (2-CYANO-ETHYL) - (3-HYDROXY-PROPYL) -AMINE HIS USE FOR PRODUCING 1- (3-HYDROXY-PROPYL) -1,4-DIAZEPANE AND 1,4-BIS (3- (3rd , 4,5-TRIMETHOXYBENZOYLOXY) -PROPYL) -DIAZEPAN | |
Fülöp et al. | Synthesis of stereoisomers 2-phenylimino-3, 1-perhydro-benzoxazines and 3, 1-perhydrobenzothiazines | |
RU2207340C2 (en) | Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazole-4-one or its pharmaceutically acceptable salts | |
KR940009533B1 (en) | Process for preparing ammoniun salts derived from hexahydrodi-benzodioxane | |
Rigo et al. | Studies on pyrrolidinones. a silylated approach to fused triazoles | |
SU339048A1 (en) | ||
Fried et al. | Some derivatives of 8-thia-3-azabicyclo [3.2. 1] octane | |
JPS6213953B2 (en) | ||
CH505828A (en) | Heterocyclic cpds C.N.S. active | |
JPH11501039A (en) | Method for producing α, β-diaminoacrylonitrile | |
BE571366A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Assignment and transfer of rights |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, MONHEIM AM R, DE Free format text: FORMER OWNER: BAYER PHARMA AKTIENGESELLSCHAFT, BERLIN, DE Effective date: 20130226 |
|
TC4A | Change of owner's name |
Owner name: BAYER PHARMA AKTIENGESELLSCHAFT, BERLIN, DE Effective date: 20130502 |
|
MK4A | Patent expired |
Expiry date: 20170226 |